Healthcare Business News
 

J&J withdraws fibroid treatment device from market


By Associated Press
Posted: July 30, 2014 - 7:30 pm ET
Tags:

Johnson & Johnson is asking surgeons not to use a line of devices for removing growths from the uterus amid regulators' growing concern that the electronic surgical tools raise the risk of spreading cancer to other parts of the body.

In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them. Surgeons use the devices to treat painful fibroids, either by removing the growths themselves or the entire uterus.

Advertisement | View Media Kit

 

J&J said Wednesday it is conducting a worldwide withdrawal of all its morcellators still on the market. The company cited an FDA meeting earlier this month that reinforced "the complexity of this issue."

FDA is weighing regulatory actions to reduce the risk of cancer spread.


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.